Investing · Page 19

Balfour Beatty Reports Positive Trading Update and Strong Contract Momentum at 2026 AGM

Dillistone Group Posts Challenging Year but Secures £1.5m Fundraise and Pivots to Acquisition-Led Growth

Dillistone's 2025 results show a tough year with revenue down 14%, but cash generation held up. Post-year-end £1.5m fundraise and shift to acquisition-led growth reshape the outlook. Cautiously positive.

MHA Trading Update: Revenue and Earnings Rise, Acquisitions Strengthen International Presence

MHA's FY26 trading update: revenue up 12%, adjusted EBITDA beats expectations, net cash rises, and acquisitions bolster international presence. Strong execution.

Hiscox Q1 2026 Trading Statement: Retail Growth Accelerates Amid Competitive Markets

Hiscox Q1 2026 trading update: Retail growth accelerates 15.1% amid competitive markets. London Market and Re face pricing pressure. Investment result dips.

HgCapital Trust Q1 2026: Strong Trading Offsets Valuation Contraction as NAV Falls 5.4%

HgCapital Trust Q1 2026 sees NAV fall 5.4% due to valuation contraction, but strong trading and premium exits provide support. Wide discount to NAV.

Coca-Cola HBC AG Reports Strong Q1 2026 Growth Amid Market Expansion

Coca-Cola HBC posts 12% revenue growth in Q1 2026, but volume gain partly due to extra selling days. Underlying trends remain solid with market share gains.

Rosebank Industries AGM Update: ECI Trading In Line, MW Components and CPM Acquisitions On Track

Rosebank Industries AGM update confirms ECI trading in line, CPM and MW Components acquisitions on track, and Main Market admission completed.

Lion Finance Group Reports Strong Q1 2026 Results, Declares Dividend and Buyback

Lion Finance Group Q1 2026: profit up 14%, ROAE 27.4%, declares dividend and launches GEL 55m buyback programme.

M&G PLC Reports Strong Q1 Net Inflows and Confident Outlook

M&G Q1 delivers £0.6bn open business net inflows, up from -£0.1bn, as Asset Management shines. Legacy drag remains, but outlook confident.

IHG posts strong Q1 RevPAR growth of 4.4%, driven by US and China

IHG delivers solid Q1 with 4.4% RevPAR growth, led by US and China. Middle East weakness noted but management confident on full-year targets. $240m buyback.

MYCELX Technologies Returns to Profitability with Strong Revenue Growth in 2025

MYCELX delivers a strong turnaround: revenue surges to $11.7m, margins improve, and the company returns to profit. But watch the cash position and customer concentration.

Metlen Energy & Metals Posts Strong Q1 2026 Results, Accelerates Strategic Transformation

Metlen Energy & Metals reports 37% revenue growth in Q1 2026 to €2.05bn, with strong performance across energy, metals, and infrastructure. Strategic transformation accelerates, but investors await profit details.

Strix Group Trading Update and Capital Return Highlights Progress Amid Challenging Markets

Strix Group FY26 trading update: steady revenue, softer profit, and a £10m cash return. Controls improve but raw material costs and CEO change loom.

Helios Towers Q1 Trading Update: Strong Growth and Guidance Upgrade

Helios Towers Q1 2026 delivers strong tenancy growth, upgrades full-year guidance – a positive signal for investors.

PetroTal Reports Strong Q1 2026 Results, Boosts EBITDA Guidance

PetroTal’s Q1 2026 EBITDA jumps 90% to $35.1M; 2026 guidance boosted to $110-120M as strong oil prices fuel cash generation.

Flutter Q1 2026: US Recovery Signs, Prediction Market Push, and LSE Listing Review

Flutter Q1 2026 shows US sportsbook recovery, FanDuel Predicts expansion, and possible LSE delisting. Revenue up 17% but net income down 38%. Full-year guidance cut.

NAHL Group Reports Strong Profit Growth and Significant Debt Reduction in FY2025 Results

NAHL reports strong profit recovery and debt reduction in FY2025. Underlying PBT up 260% to £5m, net debt down 55%. But watch the shrinking NAL case book.

Aberdeen Group to Manage Herald Investment Trust, Reaches Standstill Agreement with Saba Capital

Aberdeen Group to manage Herald Investment Trust, hires Katie Potts, signs 3-year Saba standstill. Strategic deal.

Mahindra & Mahindra Reports Full-Year Results, Proposes Record Dividend of Rs. 33 Per Share

RWS Holdings acquires Obviously Group in £40m deal to boost AI-enabled IP management

RWS Holdings completes £40m acquisition of Obviously Group, boosting AI-enabled IP management with £16.5m upfront and performance-based earn-outs.

B90 Holdings Returns to Profitability with Revenue More Than Doubling, but Auditor Flags Material Uncertainty

B90 Holdings more than doubles revenue and returns to profit, but auditor flags material uncertainty over a €0.6m legacy liability.

Ramsdens Holdings Upgrades FY26 Profit Guidance Again on Strong Gold Price and Diversified Performance

Ramsdens upgrades FY26 profit guidance again to at least £28.5m, driven by soaring gold prices and strong performance across pawnbroking, jewellery, and foreign currency.

Next PLC Q1 Sales Beat Forecasts, Profit Guidance Raised Despite Middle East Disruption

Next PLC Q1 sales beat forecasts, profit guidance raised despite Middle East disruption. Online strength offsets retail weakness.

JD Wetherspoon Trading Update: Sales Up, But Profits May Miss Expectations

Wetherspoon sales rise 3.4% but cost pressures may push profits below expectations. A mixed Q3 update for investors.

Renishaw Reports Record Q3 Revenue and Accelerating Growth

Renishaw reports record Q3 revenue, accelerating growth and a rising order book, with FY2026 guidance maintained. Strong semiconductor demand drives momentum.

Reach PLC Q1 Update: Digital Revenue Falls 8.1% as Search Disruption Continues, but Full-Year Guidance Maintained

Reach PLC Q1: Digital revenue down 8.1% on search disruption, but full-year guidance held steady.

Trainline delivers robust FY2026 results: net ticket sales up 7%, EBITDA rises 11%

Trainline FY2026: profit growth beats revenue as EBITDA rises 11%, net ticket sales up 7%, despite UK commission headwinds.

Smith+Nephew Q1 2026: In Line with Expectations, Announces $500M Buyback

Smith+Nephew Q1 2026: 3.1% underlying growth, $500M buyback, guidance unchanged. Sports medicine strong, US knees weak but no nasty surprises.

Coiled Therapeutics Annual Report Highlights Transformational Year with Positive Clinical Data for AO-252

Coiled Therapeutics' annual report reveals a strategic reset around AO-252 with 80% clinical benefit rate, but heavy dilution and pre-revenue status remain high-risk.

Animalcare Reports Strong FY25 Results Amid Recommended Acquisition by Charterhouse

Animalcare delivers strong FY25 results with 52.6% EBITDA growth, boosted by Randlab, as the recommended Charterhouse takeover at 336p takes centre stage.